Molecular surveillance of multi- and extensively drug-resistant tuberculosis transmission in the European Union from 2003 to 2011

Eurosurveillance

Volumn 19, Issue 11, 2014, Pages

  De Beer, J L ^a   Kodmon C ^b   van der Werf, M J ^b   van Ingen, J ^c   van Soolingen, D ^a,c,d  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c Department of Medical Microbiology ^*  (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CAPREOMYCIN; ISONIAZID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ADOLESCENT; ADULT; AGED; ALLELE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL TRANSMISSION; CHILD; DISEASE SURVEILLANCE; FEMALE; GENE; GENE MUTATION; GENETIC PROCEDURES; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; INHA GENE; KATG GENE; MAJOR CLINICAL STUDY; MALE; MOLECULAR FINGERPRINTING; MULTIDRUG RESISTANT TUBERCULOSIS; QUALITY CONTROL; RPOB GENE; TUBERCULOSIS CONTROL; VARIABLE NUMBER OF TANDEM REPEAT;

ANTITUBERCULAR AGENTS; CLUSTER ANALYSIS; EUROPE; EUROPEAN UNION; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MINISATELLITE REPEATS; MOLECULAR TYPING; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENY; POLYMORPHISM, GENETIC; SENTINEL SURVEILLANCE;

EID: 84896487533     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.11.20742     Document Type: Article

References (16)

1. Devaux I, Kremer K, Heersma H, Van Soolingen D. Clusters of multidrug-resistant Mycobacterium tuberculosis cases, Europe. Emerg Infect Dis. 2009; 15(7): 1052-60. http://dx. doi. org/10. 3201/eid1507. 080994.
2. Devaux I, Manissero D, Fernandez de la Hoz K, Kremer K, van Soolingen D. Surveillance of extensively drug-resistant tuberculosis in Europe, 2003-2007. Euro Surveill 2010; 15(11): pii=19518.
3. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rusch-Gerdes S, Willery E, et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol. 2006; 44(12): 4498-510. http://dx. doi. org/10. 1128/JCM. 01392-06.
4. de Beer JL, van Ingen J, de Vries G, Erkens C, Sebek M, Mulder A, et al. Comparative study of IS6110 RFLP and VNTR typing of Mycobacterium tuberculosis in the Netherlands, based on a five year nationwide survey. J Clin Microbiol. 2013; 51(4): 1193-8. http://dx. doi. org/10. 1128/JCM. 03061-12.
5. de Beer JL, Kremer K, Kodmon C, Supply P, van Soolingen D. First worldwide proficiency study on variable-number tandem-repeat typing of Mycobacterium tuberculosis complex strains. J Clin Microbiol. 2012; 50(3): 662-9. http://dx. doi. org/10. 1128/JCM. 00607-11.
6. Hillemann D, Rusch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol. 2007; 45(8): 2635-40. http://dx. doi. org/10. 1128/JCM. 00521-07.
7. Kruuner A, Hoffner SE, Sillastu H, Danilovits M, Levina K, Svenson SB, et al. Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol. 2001; 39(9): 3339-45. http://dx. doi. org/10. 1128/JCM. 39. 9. 3339-3345. 2001.
8. Franzetti F, Codecasa L, Matteelli A, Degli Esposti A, Bandera A, Lacchini C, et al. Genotyping analyses of tuberculosis transmission among immigrant residents in Italy. Clin Microbiol Infect. 2010; 16(8): 1149-54. http://dx. doi. org/10. 1111/j. 1469-0691. 2009. 03080. x.
9. Gavin P, Iglesias MJ, Jimenez MS, Rodriguez-Valin E, Ibarz D, Lezcano MA, et al. Long-term molecular surveillance of multidrug-resistant tuberculosis in Spain. Infect Genet Evol. 2012; 12(4): 701-10. http://dx. doi. org/10. 1016/j. meegid. 2011. 05. 016.
10. Parwati I, van Crevel R, van Soolingen D. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis. 2010; 10(2): 103-11. http://dx. doi. org/10. 1016/S1473-3099(09)70330-5.
11. de Steenwinkel JE, Ten Kate MT, de Knegt GJ, Kremer K, Aarnoutse RE, Boeree MJ, et al. Drug Susceptibility of Mycobacterium tuberculosis Beijing Genotype and Association with MDR TB. Emerg Infect Dis. 2012; 18(4): 660-3. http://dx. doi. org/10. 3201/eid1804. 110912.
12. Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, Bohannan BJ. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science. 2006; 312(5782): 1944-6. http://dx. doi. org/10. 1126/science. 1124410.
13. van Doorn HR, de Haas PE, Kremer K, Vandenbroucke-Grauls CM, Borgdorff MW, van Soolingen D. Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in The Netherlands. Clin Microbiol Infect. 2006; 12(8): 769-75.
14. Supply P, Lesjean S, Savine E, Kremer K, van Soolingen D, Locht C. Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J Clin Microbiol. 2001; 39(10): 3563-71. http://dx. doi. org/10. 1128/JCM. 39. 10. 3563-3571. 2001.
15. Cowan LS, Mosher L, Diem L, Massey JP, Crawford JT. Variable-number tandem repeat typing of Mycobacterium tuberculosis isolates with low copy numbers of IS6110 by using mycobacterial interspersed repetitive units. J Clin Microbiol. 2002; 40(5): 1592-602. http://dx. doi. org/10. 1128/JCM. 40. 5. 1592-1602. 2002.
16. de Beer JL, Ködmön C, van Ingen J, Supply P, van Soolingen D. Second worldwide proficiency study on variable number of tandem repeats typing of Mycobacterium tuberculosis complex. Int J Tuberc Lung Dis. 2014. Forthcoming.